Low molecular weight heparin-induced hyperkalemia and hyponatremia. Report of one case
Low molecular weight heparin-induced hyperkalemia is not an uncommon side effect. The development of hyponatremia is well described although it is less common. We report a 72-year-old woman with lumbar metastases who developed hyponatremia and hyperkalemia on the tenth day of hospitalization. Hyponatremia, with limited criteria for syndrome of inappropriate secretion of antidiuretic hormone, did not resolve with vigorous volume restriction. Hyperkalemia without an acid-base disorder or baseline renal failure, did not resolve after losartan was stopped. Enoxaparin-induced hypoaldosteronism was proposed and the drug was discontinued. After four days' persistence of the electrolyte disturbance, dexamethasone was changed to Hydrocortisone, and parameters normalized in 24 hours. The patient remained well until discharge and during outpatient control.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:149 |
---|---|
Enthalten in: |
Revista medica de Chile - 149(2021), 2 vom: 29. Feb., Seite 291-294 |
Sprache: |
Spanisch |
---|
Weiterer Titel: |
Hiponatremia e hiperpotasemia persistente inducida por enoxaparina y revertida con hidrocortisona en paciente con metástasis lumbares |
---|
Beteiligte Personen: |
Eymin, Gonzalo [VerfasserIn] |
---|
Links: |
---|
Themen: |
---|
Anmerkungen: |
Date Completed 07.09.2021 Date Revised 07.09.2021 published: Print Citation Status MEDLINE |
---|
doi: |
10.4067/s0034-98872021000200291 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM330217267 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM330217267 | ||
003 | DE-627 | ||
005 | 20231225210817.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||spa c | ||
024 | 7 | |a 10.4067/s0034-98872021000200291 |2 doi | |
028 | 5 | 2 | |a pubmed24n1100.xml |
035 | |a (DE-627)NLM330217267 | ||
035 | |a (NLM)34479277 | ||
035 | |a (PII)S0034-98872021000200291 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a spa | ||
100 | 1 | |a Eymin, Gonzalo |e verfasserin |4 aut | |
245 | 1 | 0 | |a Low molecular weight heparin-induced hyperkalemia and hyponatremia. Report of one case |
246 | 3 | 3 | |a Hiponatremia e hiperpotasemia persistente inducida por enoxaparina y revertida con hidrocortisona en paciente con metástasis lumbares |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 07.09.2021 | ||
500 | |a Date Revised 07.09.2021 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Low molecular weight heparin-induced hyperkalemia is not an uncommon side effect. The development of hyponatremia is well described although it is less common. We report a 72-year-old woman with lumbar metastases who developed hyponatremia and hyperkalemia on the tenth day of hospitalization. Hyponatremia, with limited criteria for syndrome of inappropriate secretion of antidiuretic hormone, did not resolve with vigorous volume restriction. Hyperkalemia without an acid-base disorder or baseline renal failure, did not resolve after losartan was stopped. Enoxaparin-induced hypoaldosteronism was proposed and the drug was discontinued. After four days' persistence of the electrolyte disturbance, dexamethasone was changed to Hydrocortisone, and parameters normalized in 24 hours. The patient remained well until discharge and during outpatient control | ||
650 | 4 | |a Case Reports | |
650 | 4 | |a Journal Article | |
650 | 7 | |a Heparin, Low-Molecular-Weight |2 NLM | |
773 | 0 | 8 | |i Enthalten in |t Revista medica de Chile |d 1945 |g 149(2021), 2 vom: 29. Feb., Seite 291-294 |w (DE-627)NLM00019624X |x 0717-6163 |7 nnns |
773 | 1 | 8 | |g volume:149 |g year:2021 |g number:2 |g day:29 |g month:02 |g pages:291-294 |
856 | 4 | 0 | |u http://dx.doi.org/10.4067/s0034-98872021000200291 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 149 |j 2021 |e 2 |b 29 |c 02 |h 291-294 |